March 1, 2017 / 7:44 AM / 7 months ago

BRIEF-Oasmia issues comments on chairman resignation

March 1 (Reuters) - Oasmia Pharmaceutical AB (Publ)

* Oasmia makes clarification regarding chairman Anders Lonner’s withdrawal from Board Of Directors

* Says withdrawal must be viewed against backdrop that Oasmia in no way has been able to accept Mr Lonner’s actions and demands he has made after he was elected chairman

* Lonner was elected chairman just over 3 months ago Source text for Eikon: Further company coverage: (Stockholm Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below